Justice/Resource allocation Case and Commentary Jan 2020 How Should Clinicians Respond to International Public Health Emergencies? Abbey Lowe, MA, Angela Hewlett, MD, MS, and Toby Schonfeld, PhD Balancing need for global solidarity against local stakeholders’ safety concerns is one source of tension when trying to mitigate global risk. AMA J Ethics. 2020;22(1):E16-21. doi: 10.1001/amajethics.2020.16. Medical Education Jan 2020 Five Things Students and Clinicians Should Know About “Biocontainment” Helen Stanton Chapple, PhD, RN, MSN, MA Being close enough to patients to care is as critical as remaining distant enough from a pathogen to be safe. This strategy simultaneously frustrates and supports public trust. AMA J Ethics. 2020;22(1):E22-27. doi: 10.1001/amajethics.2020.22. In the Literature Jan 2020 How Should the WHO Guide Access and Benefit Sharing During Infectious Disease Outbreaks? Nicholas G. Evans, PhD, Kelly Hills, and Adam C. Levine, MD WHO suggests doing research during outbreaks but says little about local researchers’ access to samples or subjects’ access to what’s learned. AMA J Ethics. 2020;22(1):E28-35. doi: 10.1001/amajethics.2020.28. Policy Forum Jan 2020 How Should Global Health Security Priorities Be Set in the Global North and West? Abraar Karan, MD, MPH, DTM&H Epidemics can threaten everyone on earth, yet responses are not implemented in all regions to contain disease. AMA J Ethics. 2020;22(1):E50-54. doi: 10.1001/amajethics.2020.50. Medicine and Society Oct 2019 Which Ethical Considerations Should Inform Hospice Decisions About Caring for Patients With Obesity? Chithra R. Perumalswami, MD, MSc, Brycin D. Hanslits, and Susan D. Goold, MD, MA, MHSA Current evidence suggests how hospice and palliative care clinicians can help advocate for high-quality, end-of-life care for patients with obesity. AMA J Ethics. 2019;21(10):E873-878. doi: 10.1001/amajethics.2019.873. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. State of the Art and Science Aug 2019 Are Medicaid Closed Formularies Unethical? Leah Rand, DPhil and Govind Persad, JD, PhD Closed formularies can be justified when they enable spending on other socially valuable aims, but they can single out poor patients. AMA J Ethics. 2019;21(8):E654-660. doi: 10.1001/amajethics.2019.654. Medicine and Society Aug 2019 Does Incorporating Cost-Effectiveness Analysis Into Prescribing Decisions Promote Drug Access Equity? Michael J. DiStefano, MBE and Jonathan S. Levin, MPH Advances in CEA methodology might integrate equity at the cost of transparency. AMA J Ethics. 2019;21(8):E679-685. doi: 10.1001/amajethics.2019.679. State of the Art and Science Aug 2019 Evolving Medicaid Coverage Policy and Rebates Jennifer A. Ohn, MPH and Anna Kaltenboeck, MA Ethics questions arise about the usefulness of a system that pegs Medicaid drug spending to net prices negotiated by others in the market. AMA J Ethics. 2019;21(8):E645-653. doi: 10.1001/amajethics.2019.645. Art of Medicine Aug 2019 Normal Saline Hannah Rebeccah Abrams This graphic narrative considers the shortage of normal saline in US health care organizations after Hurricane Maria devastated Puerto Rico in 2017. AMA J Ethics. 2019;21(8):E699-700. doi: 10.1001/amajethics.2019.699. Pagination First page « First Previous page ‹‹ Prev … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page ›› Next Last page Last »
Case and Commentary Jan 2020 How Should Clinicians Respond to International Public Health Emergencies? Abbey Lowe, MA, Angela Hewlett, MD, MS, and Toby Schonfeld, PhD Balancing need for global solidarity against local stakeholders’ safety concerns is one source of tension when trying to mitigate global risk. AMA J Ethics. 2020;22(1):E16-21. doi: 10.1001/amajethics.2020.16.
Medical Education Jan 2020 Five Things Students and Clinicians Should Know About “Biocontainment” Helen Stanton Chapple, PhD, RN, MSN, MA Being close enough to patients to care is as critical as remaining distant enough from a pathogen to be safe. This strategy simultaneously frustrates and supports public trust. AMA J Ethics. 2020;22(1):E22-27. doi: 10.1001/amajethics.2020.22.
In the Literature Jan 2020 How Should the WHO Guide Access and Benefit Sharing During Infectious Disease Outbreaks? Nicholas G. Evans, PhD, Kelly Hills, and Adam C. Levine, MD WHO suggests doing research during outbreaks but says little about local researchers’ access to samples or subjects’ access to what’s learned. AMA J Ethics. 2020;22(1):E28-35. doi: 10.1001/amajethics.2020.28.
Policy Forum Jan 2020 How Should Global Health Security Priorities Be Set in the Global North and West? Abraar Karan, MD, MPH, DTM&H Epidemics can threaten everyone on earth, yet responses are not implemented in all regions to contain disease. AMA J Ethics. 2020;22(1):E50-54. doi: 10.1001/amajethics.2020.50.
Medicine and Society Oct 2019 Which Ethical Considerations Should Inform Hospice Decisions About Caring for Patients With Obesity? Chithra R. Perumalswami, MD, MSc, Brycin D. Hanslits, and Susan D. Goold, MD, MA, MHSA Current evidence suggests how hospice and palliative care clinicians can help advocate for high-quality, end-of-life care for patients with obesity. AMA J Ethics. 2019;21(10):E873-878. doi: 10.1001/amajethics.2019.873.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
State of the Art and Science Aug 2019 Are Medicaid Closed Formularies Unethical? Leah Rand, DPhil and Govind Persad, JD, PhD Closed formularies can be justified when they enable spending on other socially valuable aims, but they can single out poor patients. AMA J Ethics. 2019;21(8):E654-660. doi: 10.1001/amajethics.2019.654.
Medicine and Society Aug 2019 Does Incorporating Cost-Effectiveness Analysis Into Prescribing Decisions Promote Drug Access Equity? Michael J. DiStefano, MBE and Jonathan S. Levin, MPH Advances in CEA methodology might integrate equity at the cost of transparency. AMA J Ethics. 2019;21(8):E679-685. doi: 10.1001/amajethics.2019.679.
State of the Art and Science Aug 2019 Evolving Medicaid Coverage Policy and Rebates Jennifer A. Ohn, MPH and Anna Kaltenboeck, MA Ethics questions arise about the usefulness of a system that pegs Medicaid drug spending to net prices negotiated by others in the market. AMA J Ethics. 2019;21(8):E645-653. doi: 10.1001/amajethics.2019.645.
Art of Medicine Aug 2019 Normal Saline Hannah Rebeccah Abrams This graphic narrative considers the shortage of normal saline in US health care organizations after Hurricane Maria devastated Puerto Rico in 2017. AMA J Ethics. 2019;21(8):E699-700. doi: 10.1001/amajethics.2019.699.
